Default Category
-
Pricing at Vocram Airways (A)
Fredrik Odegaard; John G. WilsonCase IVEY-9B13E013-ECorporate Governance, EntrepreneurshipIn 2010, the owner of a small air-passenger firm transports individuals and small groups to remote waterfront regions. The business serves two types of customers: private and public. The private customers can afford to pay more, while the public customers’ budget constraints limit what they can pay. The owner wants to set a single price that will maximize his expected revenue across both customer groups. A constraining factor is the plane’s limit...Starting at €8.20
-
Pricing at Vocram Airways (B)
Fredrik Odegaard; John G. WilsonCase IVEY-9B13E014-ECorporate Governance, EntrepreneurshipThis is a supplement to 9B13E013.Starting at €5.74
-
Cells For Life (B)
John G. Wilson; Robert Young; Georg Oppitz; Wayne Hoy; David BassinCase IVEY-9B09E011-ECorporate Governance, Service and Operations ManagementA biotech company receives umbilical cells for processing. A number of operational improvements are being considered in order to maintain the company's position and reputation in the market. Information on expected delivery dates is known. However, there is a great uncertainty around these dates. The company needs to take account of this variability when arranging for staffing.Starting at €5.74
-
OLGC Finds Its Match (B)
Chris K. Anderson; John G. WilsonCase IVEY-9B09E015-ECorporate Governance, Service and Operations ManagementThis supplement to OLGC Finds Its Match (A), product # 9B09E014, summarizes the results from a series of bets and provides the email response from the game provider following the discontinuation of this particular game.Starting at €5.74
-
The TELUS Share Conversion Proposal
White, Lucy; Esty, Benjamin C.; Mazzanti, LisaCase HBS-214001-EFinanceOn February 21, 2013, TELUS announced a proposal to convert the firm's non-voting shares into voting shares on a one-to-one basis, thereby eliminating the firm's dual class structure. Shareholders were scheduled to vote on the proposal at the firm's annual general meeting (AGM) on May 9, 2013. Despite strong support from management, the board, two proxy advisory firms, and several large shareholders, the proposal was opposed by Mason Capital Mana...Starting at €8.20
-
Molycorp: Financing the Production of Rare Earth Minerals (A)
Esty, Benjamin C.; Mayfield, E. ScottCase HBS-214054-EFinanceMolycorp, the western hemisphere's only producer of rare earth minerals, was in the middle of a $1 billion capital expenditure project in its effort to become a vertically integrated supplier of rare earth minerals, oxides, and metals. Yet it had just repStarting at €8.20
-
Molycorp: Morgan Brothers' Reverse Convertible Notes (C)
Esty, Benjamin C.; Mayfield, E. ScottCase HBS-215002-EFinanceIn August 2011, Morgan Brothers Bank was issuing a $2.5 million reverse convertible note with payoffs linked to the price of Molycorp's common stock. These financially engineered securities were just one of many kinds of structured notes available in the retail market. Investors must decide whether the notes were fairly priced and whether they offered a favorable risk-return trade-off.Starting at €5.74
-
London Water (B)
Vaughan S. Radcliffe; John G. Wilson; Denise BrunsdonCase IVEY-9B15B010-EAccounting and ControlSupplement to 9B15B009.Starting at €5.74
-
London Water (A)
Vaughan S. Radcliffe; John G. Wilson; Denise BrunsdonCase IVEY-9B15B009-EAccounting and ControlIn 2013, London Water, the water system of the City of London, Ontario, has run deficits for eight of the past nine years, leading to significant pressure to pull the organization out of the red. The Water Engineering Division manager knows that something needs to change. Overhauling the rate structure is an attractive option; however, myriad political, economic and environmental issues are at play. Moreover, as steward of one of the city’s most ...Starting at €8.20
-
Cells For Life (A)
John G. Wilson; Robert Young; Georg Oppitz; Wayne Hoy; David BassinCase IVEY-9B09E010-ECorporate Governance, Service and Operations ManagementA biotech company receives umbilical cells for processing. A number of operational improvements are being considered in order to maintain the company's position and reputation in the market. Information on expected delivery dates is known. However, there is a great uncertainty around these dates. The company needs to take account of this variability when arranging for staffing. A supporting data set is available, product 7B09E010 for the (A) case...Starting at €8.20